News
More support for MDMA-assisted psychotherapy for PTSD
- Author:
- Megan Brooks
The full data from MAPP2 are expected to be published in a peer-reviewed journal later this year.
News
Novel antipsychotic ‘encouraging’ for resistant schizophrenia
- Author:
- Megan Brooks
New therapeutic options for TRS, which occurs in about one-third of patients, are “desperately needed,” said Dr. Ravi Anand.
News
Renowned stroke expert Ralph L. Sacco, MD, dies
- Author:
- Megan Brooks
Dr. Sacco, the only physician to have served as president of both the American Heart Association and American Academy of Neurology, was 65.
News
Diet packed with fast food found hard on the liver
- Author:
- Megan Brooks
“Striking” elevations in steatosis were evident among persons with obesity and diabetes who consumed fast food, in comparison with their...
News
Can 6 minutes of intense cycling put the brakes on Alzheimer’s?
- Author:
- Megan Brooks
Six minutes of high-intensity cycling increased circulating levels of brain-derived neurotrophic factor to a significantly greater extent than...
News
‘Clinical paradox’? Bariatric surgery may protect from GI cancers
- Author:
- Megan Brooks
The study marks “an important step toward improving the understanding of potential lifetime risks of bariatric surgery and overall major health...
News
Two novel JAK inhibitors show promise in ulcerative colitis
- Author:
- Megan Brooks
“As JAK inhibitors are associated with increased risk of major cardiovascular events and venous thromboembolisms, larger studies are needed for...
News
Arkansas cardiologist pays $900K to settle false claims allegations
- Author:
- Megan Brooks
As part of the settlement, the doctor will enter into an integrity agreement with the US Department of Health & Human Services.
News
Strong support to provide DAA therapy to all patients with HCV
- Author:
- Megan Brooks
The findings highlight a “substantial need to provide DAA therapy to all patients with HCV, regardless of disease stage or financial status.”
News
FDA approves second antiamyloid for Alzheimer’s disease
- Author:
- Megan Brooks
Like its controversial cousin aducanumab, lecanemab was approved under the FDA’s accelerated approval pathway.
News
Heart benefits begin at well under 10,000 daily steps
- Author:
- Megan Brooks
The benefits of taking more daily steps accrue at well below the widely promoted threshold of 10,000 steps per day.
News
Top cardiology societies call for revamp of clinical trials
- Author:
- Megan Brooks
Clinical trials have become too costly and burdensome, and it’s time to reinvent how they are conducted, leading cardiology societies say in a...
News
Vonoprazan triple therapy most cost-effective for H. pylori: Study
- Author:
- Megan Brooks
Rifabutin triple therapy (Talicia) is the second most cost-effective strategy for H. pylori eradication.
News
Strong link between muscle strength, mobility, and brain health
- Author:
- Megan Brooks
“The implication is that muscular strength and mobility influence brain health.”
News
Two exercise interventions may ease acute, subacute spine pain
- Author:
- Megan Brooks
Compared to usual primary care, both interventions reduced pain-related disability at 3 months and these changes were sustained.